Medicalgorithmics

Medicalgorithmics FCF/Debt

The Free Cash Flow to Debt Ratio of Medicalgorithmics (MDG.WA) as of Nov 22, 2026 is -9.47 %. In the previous year, Free Cash Flow to Debt Ratio was -557.50 % — a change of -98.30% (higher).

FCF/Debt

-9.47 %

YoY

-98.30%

Last updated:

Free Cash Flow to Debt Ratio of Medicalgorithmics is 2025 -9.47 % . Free Cash Flow to Debt Ratio of Medicalgorithmics was 2024 -557.50 % . It decreases by -98.30% higher compared to the previous year.

The Medicalgorithmics FCF/Debt history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

FCF/Debt
Date
FCF/Debt
Jan 1, 2018
57.09 PLN
Jan 1, 2019
11.79 PLN
Jan 1, 2020
-22.75 PLN
Jan 1, 2021
-231.88 PLN
Jan 1, 2022
-67,144.44 PLN
Jan 1, 2023
-195.80 PLN
Jan 1, 2024
-557.50 PLN
Jan 1, 2025
-9.47 PLN
The Medicalgorithmics FCF/Debt history
YEARFCF/DebtYoY
-9.47 %-98.30%
-557.50 %+184.73%
-195.80 %-99.71%
-67,144.44 %+28,856.38%
-231.88 %+919.08%
-22.75 %-292.94%
11.79 %-79.34%
57.09 %-549.28%
-12.71 %-136.43%
34.89 %-99.93%
47,732.25 %-115.97%
-298,822.22 %—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Medicalgorithmics Stock analysis

What does Medicalgorithmics do? Medicalgorithmics SA develops and manufactures the PocketECG system for remote heart arrhythmia diagnosis and monitoring, used in clinical drug trials for cardiac safety. The company provides IT and biotechnology services, scientific R&D in natural sciences, and works on tele-rehabilitation cardiology devices, hospital task optimization software, and remote ECG description systems. Its products serve healthcare providers, pharmaceutical companies conducting cardiac safety trials, and medical institutions requiring remote cardiac monitoring solutions. The firm operates through MEDICALGORITHMICS US HOLDING CORPORATION and Medi-Lynx Cardiac Monitoring LLC, offering diagnostic technology and related services to global healthcare markets. Medicalgorithmics is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Medicalgorithmics stock

Free Cash Flow to Debt Ratio of Medicalgorithmics is -9.47 % in 2025.

Free Cash Flow to Debt Ratio of Medicalgorithmics changed from -557.50 % to -9.47 %, representing a -98.30% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of Free Cash Flow to Debt Ratio Medicalgorithmics since 2006 – with annual values, charts, and detailed analysis.

FCF/Debt measures the percentage of total debt that could be repaid from free cash flow. It is a stricter measure than OCF/Debt as it accounts for capital expenditures.

A 'good' varies by industry and company stage. On Eulerpool, you can compare Free Cash Flow to Debt Ratio's Medicalgorithmics with sector peers and the industry average to assess whether it is attractive.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Leverage — Medicalgorithmics

All Key Metrics — Medicalgorithmics